Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01701115 · ClinicalTrials.gov registry record · NA
Effect of Local Anesthetic Dose on Interscalene Block
A NA study, sponsored by Hospital for Special Surgery, New York.
- Completed
- Registry status
- NA
- Development phase
- 154
- Enrollment target
NCT01701115 is a NA study that has completed, run by Hospital for Special Surgery, New York. The registered enrollment target is 154 participants.
The verdict
NCT01701115, a NA study, has completed, sponsored by Hospital for Special Surgery, New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 154 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if a decrease in the standard volume of local anesthetic used to numb your shoulder area before shoulder arthroscopy will provide adequate anesthesia for the procedure and decrease the amount of time until you are ready for discharge from the hospital.
Interventions
- PROCEDURE Low Dose (20 ml) Local Anesthetic Volume for Interscalene Block
- PROCEDURE Control Dose (40 mL) Local Anesthetic Volume for Interscalene Block
- DRUG Low Dose (20 mL) Local Anesthetic (Mepivacaine:Bupivacaine)
- DRUG Control Dose (40 mL) Local Anesthetic (Mepivacaine:Bupivacaine)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2012-08 |
| Est. Completion | 2013-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01701115
The ClinicalTrials.gov registry entry for NCT01701115 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Low Dose (20 ml) Local Anesthetic Volume for Interscalene Block is the first listed.
NCT01701115 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01701115 about?
NCT01701115 is a clinical study titled "Effect of Local Anesthetic Dose on Interscalene Block". The purpose of this study is to determine if a decrease in the standard volume of local anesthetic used to numb your shoulder area before shoulder arthroscopy will provide adequate anesthesia for the procedure and decrease the amount of time until you are ready for discharge from the hospital.
What is the current status of trial NCT01701115?
This trial is currently completed. It is a NA study. The enrollment target is 154 participants. The study started on 2012-08. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01701115?
The interventions under investigation include: Low Dose (20 ml) Local Anesthetic Volume for Interscalene Block (PROCEDURE), Control Dose (40 mL) Local Anesthetic Volume for Interscalene Block (PROCEDURE), Low Dose (20 mL) Local Anesthetic (Mepivacaine:Bupivacaine) (DRUG), Control Dose (40 mL) Local Anesthetic (Mepivacaine:Bupivacaine) (DRUG).
Who is sponsoring clinical trial NCT01701115?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.